Literature DB >> 11360216

Travel and the introduction of human immunodeficiency virus type 1 non-B subtype genetic forms into Western countries.

M M Thomson1, R Nájera.   

Abstract

Both high mutation rates and recombination contribute to the genetic diversity of human immunodeficiency virus type 1 (HIV-1). Among viruses of the main group, which are responsible for the HIV-1 pandemic, 21 circulating genetic forms have been reported, 11 of which are recombinant between > or = 2 subtypes. In Western Europe and the Americas, the HIV-1 epidemic is largely dominated by B subtype viruses; however, infections with diverse non-B subtype genetic forms are increasingly being recognized. In Western Europe and North America, most of them have been identified in immigrants or travelers returning from areas with high HIV-1 prevalence, mainly from sub-Saharan Africa and Southeast Asia, where non-B subtype genetic forms predominate, but propagation within other groups has been reported in some Western countries. This may have implications for prophylactic and therapeutic strategies and, by bringing in contact different genetic forms, may favor the generation of novel recombinant viruses. Travelers from different categories--including immigrants, military personnel, seamen, tourists, expatriates, diplomats, and businessmen--may be at risk of transporting HIV non-B subtype genetic forms to Western countries.

Entities:  

Mesh:

Year:  2001        PMID: 11360216     DOI: 10.1086/320764

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  24 in total

1.  Enhancing HIV/AIDS and STD prevention through program integration.

Authors:  Jack Jourden; Paul Etkind
Journal:  Public Health Rep       Date:  2004 Jan-Feb       Impact factor: 2.792

2.  Natural killer cell-mediated innate sieve effect on HIV-1: the impact of KIR/HLA polymorphism on HIV-1 subtype-specific acquisition in east Africa.

Authors:  Rebecca N Koehler; Galit Alter; Sodsai Tovanabutra; Elmar Saathoff; Miguel A Arroyo; Anne M Walsh; Eric E Sanders-Buell; Leonard Maboko; Michael Hoelscher; Merlin L Robb; Nelson L Michael; Francine E McCutchan; Jerome H Kim; Gustavo H Kijak
Journal:  J Infect Dis       Date:  2013-08-06       Impact factor: 5.226

3.  Molecular epidemiology of HIV type 1 CRF02_AG in Cameroon and African patients living in Italy.

Authors:  Nazle Mendonca Collaço Véras; Maria Mercedes Santoro; Rebecca R Gray; Andrew J Tatem; Alessandra Lo Presti; Flaminia Olearo; Giulia Cappelli; Vittorio Colizzi; Desiré Takou; Judith Torimiro; Gianluca Russo; Annapaola Callegaro; Romina Salpini; Roberta D'Arrigo; Carlo-Federico Perno; Maureen M Goodenow; Massimo Ciccozzi; Marco Salemi
Journal:  AIDS Res Hum Retroviruses       Date:  2011-05-06       Impact factor: 2.205

4.  Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy.

Authors:  Philippa J Easterbrook; Mel Smith; Jane Mullen; Siobhan O'Shea; Ian Chrystie; Annemiek de Ruiter; Iain D Tatt; Anna Maria Geretti; Mark Zuckerman
Journal:  J Int AIDS Soc       Date:  2010-02-03       Impact factor: 5.396

Review 5.  Dilemma of concepts and strategies for the prevention of spread of HIV in relation to human behavior, law and human rights.

Authors:  Reinhard H Dennin; Michael Lafrenz; Arndt Sinn; Lan-juan Li
Journal:  J Zhejiang Univ Sci B       Date:  2011-07       Impact factor: 3.066

6.  Genomic Diversity of Human Immunodeficiency Viruses.

Authors:  R M Gupta; A K Sahni; J Jena; S K Nema
Journal:  Med J Armed Forces India       Date:  2011-05-30

7.  Travel patterns and risk behaviour of HIV-positive people travelling internationally.

Authors:  Irving E Salit; Marie Sano; Andrea K Boggild; Kevin C Kain
Journal:  CMAJ       Date:  2005-03-29       Impact factor: 8.262

8.  Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors.

Authors:  Eric Delwart; Elizabeth Slikas; Susan L Stramer; Hany Kamel; Debra Kessler; David Krysztof; Leslie H Tobler; Danielle M Carrick; Whitney Steele; Deborah Todd; David J Wright; Steven H Kleinman; Michael P Busch
Journal:  J Infect Dis       Date:  2012-01-31       Impact factor: 5.226

9.  HIV-1 Subtype distribution in morocco based on national sentinel surveillance data 2004-2005.

Authors:  Mohammed Akrim; Sanae Lemrabet; Elmir Elharti; Rebecca R Gray; Jean Claude Tardy; Robert L Cook; Marco Salemi; Patrice Andre; Taj Azarian; Rajae El Aouad
Journal:  AIDS Res Ther       Date:  2012-02-14       Impact factor: 2.250

10.  Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach.

Authors:  Dimitrios Paraskevis; Oliver Pybus; Gkikas Magiorkinis; Angelos Hatzakis; Annemarie Mj Wensing; David A van de Vijver; Jan Albert; Guiseppe Angarano; Birgitta Asjö; Claudia Balotta; Enzo Boeri; Ricardo Camacho; Marie-Laure Chaix; Suzie Coughlan; Dominique Costagliola; Andrea De Luca; Carmen de Mendoza; Inge Derdelinckx; Zehava Grossman; Osama Hamouda; Im Hoepelman; Andrzej Horban; Klaus Korn; Claudia Kücherer; Thomas Leitner; Clive Loveday; Eilidh Macrae; I Maljkovic-Berry; Laurence Meyer; Claus Nielsen; Eline Lm Op de Coul; Vidar Ormaasen; Luc Perrin; Elisabeth Puchhammer-Stöckl; Lidia Ruiz; Mika O Salminen; Jean-Claude Schmit; Rob Schuurman; Vincent Soriano; J Stanczak; Maja Stanojevic; Daniel Struck; Kristel Van Laethem; M Violin; Sabine Yerly; Maurizio Zazzi; Charles A Boucher; Anne-Mieke Vandamme
Journal:  Retrovirology       Date:  2009-05-20       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.